Oral Solid Dosage Contract Manufacturing Market 2030: Driving Forces Behind Market Expansion
Market Size & Trends
The global oral solid dosage contract manufacturing market size was estimated at USD 36.50 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.97% from 2024 to 2030. Growth in the market can be attributed to the increasing advancements in drug delivery technology, including targeted drug delivery & sustained release dosage forms, investments by contract development manufacturing organizations to expand the oral solid dosage development, and demand for novel therapies.
In addition, oral pharmaceutical products are likely to be replaced with new technologies anytime shortly. For instance, integrating 3D printing in OSD manufacturing can enable precise control over drug release and help customize dosage forms based on patient needs. This technology allows for the production of complex shapes and formulations, offering flexibility in drug design & manufacturing. Hence, the solid dose pharmaceutical manufacturing expansion is driven by solid dose formats & increased efficiency.
Gather more insights about the market drivers, restrains and growth of the Global Oral Solid Dosage Contract Manufacturing Market
Detailed Segmentation
Product Type Insights
Based on product type, the tablets segment held the largest market share of 32.7% in 2023.Solid dosage forms, specifically tablets, are recognized as cost-effective pharmaceuticals. The expected rise in demand for these products is poised to drive growth within this segment.
Mechanism Insights
Based on mechanism, the controlled release segment accounted for 52.2% of the market share in 2023. This drug delivery mechanism maintains a consistent drug concentration in the tissues and bloodstream over an extended duration. Recent advancements in oral CR delivery systems, including intestinal patches, polymer nanosystems, dome tablets, dual drug tablets, and bioinspired delivery methods, such as exosomes, have revolutionized the field.
End-use Insights
Based on end-use, the large size companies segment accounted for 54.8% of the market share in 2023. Large pharmaceutical companies outsource oral solid dose formulations & manufacturing, attributing quality & reliability as the top two positions; however, priorities diverge from there. Besides, established pharma ranks productivity second, followed by affordability, innovation, and regulation. On the other hand, Contract Manufacturing Organizations (CMOs) specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption.
Regional Insights
Asia Pacific dominated the global oral solid dosage contract manufacturing market in 2023, holding a revenue share of 34.8%. This growth can be attributed to various factors, such as improved social insurance schemes and constantly improving economic conditions in the region, which allow patients to pay out-of-pocket pharmaceutical costs. In recent years, countries such as Singapore, China, and India have been observed to be major players in the pharmaceutical industry owing to their expanding capabilities of the oral solid dosage contract manufacturing process.
Key Companies & Market Share Insights
Participants are acquiring various strategic initiatives to strengthen their market position, offering diverse services globally. The prominent strategies adopted by companies are acquisitions, collaborations, expansion, services launches, partnerships, and others to increase market presence & revenue and gain a competitive edge. These initiatives may be implemented to expand regionally or widen the global network to reach more customers.
Browse through Grand View Research's Medical Devices Industry Research Reports.
- Vital Signs Monitoring Devices Market Size, Share & Trends Analysis Report By Product (BP Monitors, Pulse Oximeters), By End-use (Hospitals, Ambulatory Centers), By Region, And Segment Forecasts, 2023 - 2030
- Surgical Microscopes Market Size, Share & Trends Analysis Report By Type (On Casters, Wall Mounted, Tabletop), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030
Key Oral Solid Dosage Contract Manufacturing Companies:
- Catalent, Inc.
- Lonza
- Aenova Group
- Boehringer Ingelheim International GmbH
- Jubilant Pharmova Limited
- Patheon Pharma Services
- Recipharm AB.
- Corden Pharma International
- Siegfried Holding AG
- Piramal Pharma Solutions
- AbbVie Contract Manufacturing
- Next Pharma AB
Oral Solid Dosage Contract Manufacturing Market Segmentation
Grand View Research has segmented the global oral solid dosage contract manufacturing market based on product type, mechanism, service, drug potency, prescription type, therapeutic area, end-use, region:
Oral Solid Dosage Contract Manufacturing Product Type Outlook (Revenue, USD Million, 2018 - 2030)
- Tablets
- Capsules
- Powders
- Granules
- Others
Oral Solid Dosage Contract Manufacturing Mechanism Outlook (Revenue, USD Million, 2018 - 2030)
- Immediate Release
- Delayed Release
- Controlled Release
Oral Solid Dosage Contract Manufacturing Service Outlook (Revenue, USD Million, 2018 - 2030)
- Drug Product Development
- Fill Finish Product Manufacturing
- API Manufacturing
- Others
Oral Solid Dosage Contract Manufacturing Drug Potency Outlook (Revenue, USD Million, 2018 - 2030)
- High Potent Drugs
- Moderate Potent Drugs
- Low Potent Drugs
Oral Solid Dosage Contract Manufacturing Prescription Type Outlook (Revenue, USD Million, 2018 - 2030)
- Prescription Drugs
- Over-The-Counter Drugs
Oral Solid Dosage Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Cardiovascular Diseases
- Metabolic Disorders
- Neurological Disorders
- infectious Diseases
- Gastrointestinal Diseases
- Other Therapeutic Areas
Oral Solid Dosage Contract Manufacturing End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Large Size Companies
- Medium & Small Size Companies
- Others
Oral Solid Dosage Contract Manufacturing Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Order a free sample PDF of the Oral Solid Dosage Contract Manufacturing Market Intelligence Study, published by Grand View Research.
Recent Developments
- In July 2023, Aenova Group and Galvita entered a strategic partnership to improve oral dosage forms’ development, formulation, and production. This collaboration aims to bring Galvita’s child- and senior-specific knowledge of formulations featuring better taste masking, faster oral disintegration, and higher drug loading to Aenova’s currently available portfolio of oral dosage forms in the market.
- In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity. The investment is attributed to the increasing demand for film-coated tablets, conventional oral solids tablets, and hard capsules.
- In March 2023, the clinical and commercial drug product manufacturing line in Visp was completed by Lonza. The expansion will support the company in strengthening its drug product services offering. The manufacturing unit is part of Lonza’s Ibex Biopark, which includes mammalian manufacturing, bioconjugation, and microbial development.
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Explore Horizon, the world's most expansive market research database
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian